Sporadic breast cancers exhibit loss of heterozygosity on chromosome segment 10q23 close to the Cowden disease locus
- PMID: 9491329
Sporadic breast cancers exhibit loss of heterozygosity on chromosome segment 10q23 close to the Cowden disease locus
Abstract
Cowden disease, a dominantly inherited syndrome characterized by a variety of proliferative lesions and predisposition to breast and thyroid cancer, has recently been linked to the polymorphic marker D10S215 on chromosome segment 10q23. Loss of heterozygosity in prostate cancer is linked to the same marker, whereas loss of heterozygosity in glioblastoma, endometrial cancer, and other malignancies also localizes to this region. Most recently, a putative tumor suppressor gene (PTEN/MMAC1) has been identified in the region between D10S215 and an adjacent, more telomeric marker (D10S541) and was found to be altered in breast cancers, prostate cancers, and glioblastomas. We examined 22 invasive breast cancers for loss of heterozygosity in the 10q23 region and found loss in 41% (9/22). There were two distinct regions of loss, including one near the D10S541 marker, with an approximately equal frequency of deletion in each. The observed pattern of deletion is consistent with the presence of a tumor suppressor gene between D10S215 and D10S541. Most of the poorly differentiated carcinomas in the case collection showed loss of heterozygosity in the region near D10S215, suggesting that this loss correlates with a poor prognosis.
Similar articles
-
Differential loss of heterozygosity in the region of the Cowden locus within 10q22-23 in follicular thyroid adenomas and carcinomas.Cancer Res. 1997 Feb 1;57(3):500-3. Cancer Res. 1997. PMID: 9012481
-
Loss of heterozygosity in human breast carcinomas in the ataxia telangiectasia, Cowden disease and BRCA1 gene regions.Oncogene. 1997 Jan 23;14(3):339-47. doi: 10.1038/sj.onc.1200818. Oncogene. 1997. PMID: 9018120
-
Allele loss on chromosome 16q24.2-qter occurs frequently in breast cancers irrespectively of differences in phenotype and extent of spread.Cancer Res. 1994 Jan 15;54(2):513-7. Cancer Res. 1994. PMID: 8275489
-
Cowden disease or multiple hamartoma syndrome--cutaneous clue to internal malignancy.Eur J Dermatol. 2002 Sep-Oct;12(5):411-21. Eur J Dermatol. 2002. PMID: 12370126 Review.
-
Cowden syndrome (multiple hamartoma syndrome).Dermatol Clin. 1995 Jan;13(1):27-31. Dermatol Clin. 1995. PMID: 7712647 Review.
Cited by
-
The impact of PTEN tumor suppressor gene on acquiring resistance to tamoxifen treatment in breast cancer patients.Cancer Biol Ther. 2012 Oct;13(12):1165-74. doi: 10.4161/cbt.21346. Epub 2012 Aug 15. Cancer Biol Ther. 2012. PMID: 22892847 Free PMC article.
-
Alteration of Akt activity increases chemotherapeutic drug and hormonal resistance in breast cancer yet confers an achilles heel by sensitization to targeted therapy.Adv Enzyme Regul. 2008;48:113-35. doi: 10.1016/j.advenzreg.2008.02.006. Epub 2008 Feb 21. Adv Enzyme Regul. 2008. PMID: 18423407 Free PMC article.
-
Involvement of Akt and mTOR in chemotherapeutic- and hormonal-based drug resistance and response to radiation in breast cancer cells.Cell Cycle. 2011 Sep 1;10(17):3003-15. doi: 10.4161/cc.10.17.17119. Epub 2011 Sep 1. Cell Cycle. 2011. PMID: 21869603 Free PMC article.
-
PTEN in Hereditary and Sporadic Cancer.Cold Spring Harb Perspect Med. 2020 Apr 1;10(4):a036087. doi: 10.1101/cshperspect.a036087. Cold Spring Harb Perspect Med. 2020. PMID: 31570378 Free PMC article. Review.
-
Roles of the Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR pathways in controlling growth and sensitivity to therapy-implications for cancer and aging.Aging (Albany NY). 2011 Mar;3(3):192-222. doi: 10.18632/aging.100296. Aging (Albany NY). 2011. PMID: 21422497 Free PMC article. Review.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials